Epidermal growth factor contamination and concentrations of intact human chorionic gonadotropin in commercial preparations

Fertility and Sterility

Volumn 82, Issue 1, 2004, Pages 232-233

  Yarram, Sarah J ^a   Jenkins, Julian ^a   Cole, Lawrence A ^b   Brown, Nathan L ^a   Sandy, Jonathan R ^a   Mansell, Jason P ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY OF NEW MEXICO   (United States)

Author keywords

beta core; Choragon; contamination; EGF; hCG; Pregnyl; Profasi; recombinant

Indexed keywords

CHORIONIC GONADOTROPIN; EPIDERMAL GROWTH FACTOR; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT HORMONE;

ARTICLE; CONTROLLED STUDY; DRUG CONTAMINATION; DRUG EFFICACY; DRUG SAFETY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; IMMUNOASSAY; PRIORITY JOURNAL; URINE;

CHORIONIC GONADOTROPIN; DRUG COMPOUNDING; DRUG CONTAMINATION; DRUG INDUSTRY; EPIDERMAL GROWTH FACTOR; HUMANS; OSMOLAR CONCENTRATION;

EID: 3242757533     PISSN: 00150282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.fertnstert.2003.11.051     Document Type: Article

References (12)

1. Chang P., Kenley S., Burns T., Denton G., Currie K., DeVane G., O'Dea L. Recombinant human chorionic gonadotropin (rhCG) in assisted reproductive technology results of a clinical trial comparing two doses of rhCG (Ovidrel) to urinary hCG (Profasi) for induction of final follicular maturation in in vitro fertilization-embryo transfer. Fertil Steril. 76:2001;67-74
2. Cole L.A., Shahabi S., Butler S., Mitchell H., Newlands E.S., Behrman H.R., Verrill H.L. Utility of commonly used commercial hCG immunoassays in the diagnosis and management of trophoblastic diseases. Clin Chem. 47:2001;308-315
3. Lunardi-Iskandar Y., Bryant J.L., Zeman R.A., Lam V.H., Samaniego F., Besnier J.M., et al. Tumorigenesis and metastasis of neoplastic Kaposi's sarcoma cell line in immunodeficient mice blocked by a human pregnancy hormone. Nature. 375:(6526):1995;64-68
4. Kauffman H.F., Hovenga H., de Bruijn H.W., Beintema J.J. Eosinophil-derived neurotoxin (EDN) levels in commercial human urinary preparations of glycoprotein hormones. Eur J Obstet Gynecol Reprod Biol. 82:1999;111-113
5. Rolfe B.E., Morton H., Clarke F.M. Early pregnancy factor is an immunosuppressive contaminant of commercial preparations of human chorionic gonadotrophin. Clin Exp Immunol. 51:1983;45-52
6. Morse J.H., Lustbader J.W., Harrington J.W., Canfield R.E. Heterogeneity of proteins in commercial preparations of human chorionic gonadotrophin (hCG) demonstrated by Western blotting. Am J Reprod Immunol Microbiol. 17:1998;134-140
7. Daja M.M., Hiyama J., Scott G.K., Renwick A.G. The detection and isolation of protease activity associated with purified preparations of human chorionic gonadotrophin. Endocrinology. 132:1993;1766-1773
8. Reichl H., Balen A., Jansen C.A.M. Prion transmission in blood and urine what are the implications for recombinant and urinary-derived gonadotropins? Hum Reprod. 17:2002;2501-2508
9. Knox G.E., Reynolds D.W., Cohen S., Alford C.A. Alteration of the growth of cytomegalovirus and herpes simplex virus type 1 by epidermal growth factor, a contaminant of crude human chorionic gonadotropin preparation. J Clin Invest. 61:1978;1635-1644
10. Hofmann J., Holzel F., Hackenberg R., Schulz K.D. Characterization of epidermal growth factor-related protein from human urinary chorionic gonadotrophin. J Endocrinol. 123:1989;333-340
11. Watanabe H. Epidermal growth factor in urine of pregnant women and in amniotic fluid throughout pregnancy. Gynecol Endocrinol. 4:1990;43-50
12. Butler S.A., Iles R.K. Ectopic human chorionic gonadotropin β secretion by epithelial tumors and human chorionic gonadotropin β-induced apoptosis in Kaposi's sarcoma Is there a connection? Clin Cancer Res. 9:2003;4666-4673